Loading news...
SelectQuote is downgraded to sell as Medicare Advantage reimbursement shocks threaten its core business model. SLQT's fundamentals are deteriorating, with Senior segment profitability slipping and commission revenue at risk from insurer belt-tightening. The 2027 Medicare reimbursement rate increase of just 0.09% is far below expectations, likely pressuring insurer and broker margins.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its fiscal second quarter 2026 financial results before market open on Thursday, February 5, 2026. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (February 5, 2026) at 8:00 am ET to discuss the re.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced that its SelectRx pharmacy recently reached a new, multiyear agreement with a significant, long-time PBM (pharmacy benefit manager) partner. The new strategic agreement bolsters financial consistency and stability across both organizations. This agreement, which took effect on Janua.
BOSTON, Jan. 13, 2026 /PRNewswire/ -- Pathlight Capital LP ("Pathlight" or "Pathlight Capital") today announced that it is serving as the Administrative Agent on a $415 million senior secured credit facility for SelectQuote, Inc. ("SelectQuote," "SLQT" or the "Company"), a distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform. As part of the facility, Pathlight underwrote and provided a $325 million term loan.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the successful completion of a new $415 million credit facility comprised of a $325 million term loan facility with Pathlight Capital LP (“Pathlight”) and an enhanced $90 million revolving credit facility with UMB Bank (“UMB”). The new credit facility immediately strengthens the com.
James River Group (NASDAQ: JRVR - Get Free Report) and SelectQuote (NYSE: SLQT - Get Free Report) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Volatility and Risk James River Group has
Yuanbao (NASDAQ: YB - Get Free Report) and SelectQuote (NYSE: SLQT - Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Valuation and Earnings This table compares Yuanbao and SelectQuote"s
BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers.
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers.
SelectQuote (NYSE: SLQT - Get Free Report) and Radian Group (NYSE: RDN - Get Free Report) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings
BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers.
SelectQuote faces mounting challenges, including weaker growth in its core SelectRx segment and heightened industry headwinds impacting policy sales and retention. SLQT's revenue mix is shifting toward recurring pharmacy benefits, but razor-thin margins and recent member losses raise concerns about long-term profitability. Despite trading at a low 5x EV/FY26 adjusted EBITDA, SLQT's high debt load and uncertain outlook make its valuation less compelling.
SelectQuote, Inc. ( SLQT ) Q1 2026 Earnings Call November 6, 2025 8:30 AM EST Company Participants Matthew Gunter Timothy Danker - CEO & Director Ryan Clement - Chief Financial Officer William Grant - Chief Operating Officer Conference Call Participants Michael Murray - RBC Capital Markets, Research Division Patrick McCann - NOBLE Capital Markets, Inc., Research Division Presentation Operator Welcome to SelectQuote's First Quarter Earnings Conference Call. [Operator Instructions] It is now my pleasure to introduce Matt Gunter, SelectQuote Investor Relations.
SelectQuote (SLQT) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.26 per share a year ago.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the first quarter of fiscal year 2026 of $328.8 million compared to consolidated revenue for the first quarter of fiscal year 2025 of $292.3 million. Consolidated net loss for the first quarter of fiscal year 2026 was $30.5 million compared to consolidated net loss for the first quarter of fiscal year 2025 of $44.5 million. Finally, consolidated Adjusted EBITDA* for the first quarter of fiscal.
SelectQuote (NYSE: SLQT - Get Free Report) is expected to announce its Q1 2026 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $323.6820 million for the quarter. SelectQuote has set its FY 2026 guidance at EPS.Individuals can check the company's upcoming
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its first quarter 2026 financial results before market open on Thursday, November 6, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (November 6, 2025) at 8:30 am ET to discuss the results. T.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today released a new research brief offering in-depth insights into the complex medical and social needs of the population it serves. The findings from tens of thousands of patient health needs assessments gathered by the Company's Healthcare Select division highlight significant challenges across.
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of SelectQuote, Inc. (NYSE: SLQT). Investors who purchased shares of SelectQuote, Inc. (NYSE: SLQT) prior to September 2020 and continue to hold any of those NYSE: SLQT shares also have certain options and should contact he Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SelectQuote To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 10, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE:SLQT) and reminds investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.